KEYTRUDA

KEYTRUDA

Displaying 10 out of 13 results

  1. New Content Item

    Merck's Keytruda wins FDA approval to treat head and neck cancer

  2. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's Keytruda sets new five-year survival standard for advanced lung cancer

    Nearly a quarter of patients who received Merck & Co's immunotherapy Keytruda as an initial treatment for advanced lung cancer were still alive ...
  3. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's Keytruda fails as monotherapy in breast cancer study

    Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the treatment as a ...
  4. The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's first-quarter profit beats on Keytruda boost

    Merck & Co Inc reported a higher-than-expected first-quarter profit on Tuesday and raised its earnings and sales forecasts for the year, thanks to ...
  5. New Content Item

    Merck's Keytruda wins FDA approval as combination therapy for kidney cancer

    The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer therapy, Keytruda, as part of a combination therapy for previously ...
  6. The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's Keytruda fails late-stage study in liver cancer patients

    Merck & Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a ...
  7. A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca

    Merck, Pfizer drug combo extends kidney cancer survival: study

    A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those ...
  8. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck to further study Keytruda in prostate cancer after early success

    Merck & Co Inc said on Thursday it was launching three late-stage studies for its cancer immunotherapy Keytruda as a combination treatment for ...
  9. A view of the Merck & Co. campus in Linden, New Jersey

    Merck raised prices five drugs including Keytruda in November

    Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including ...
  10. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck drug Keytruda succeeds in late-stage esophageal cancer trial

    U.S. drugmaker Merck & Co said on Wednesday its blockbuster cancer drug Keytruda met the main goal of a late-stage trial, of extending the lives ...